Characteristics and outcomes of gemcitabine-associated pulmonary hypertension

Background Despite its known cardiac and lung toxicities, the chemotherapy drug gemcitabine has only rarely been associated with pulmonary hypertension (PH), and the underlying mechanism remains unclear. The objective of the present study was to assess the association between gemcitabine and PH. Met...

Full description

Bibliographic Details
Main Authors: Pierre Mouillot, Nicolas Favrolt, Charles Khouri, Aurélie Grandvuillemin, Marie-Camille Chaumais, Déborah Schenesse, Andrei Seferian, Xavier Jais, Laurent Savale, Guillaume Beltramo, Olivier Sitbon, Jean-Luc Cracowski, Marc Humbert, Marjolaine Georges, Philippe Bonniaud, David Montani
Format: Article
Language:English
Published: European Respiratory Society 2024-05-01
Series:ERJ Open Research
Online Access:http://openres.ersjournals.com/content/10/3/00654-2023.full